Udit Batra

Udit Batra leads Waters Corporation as President and CEO, overseeing a leading provider of analytical instruments and software used in laboratories worldwide. Waters' core products are high-performance liquid chromatography (HPLC) systems and mass spectrometry instruments — sophisticated analytical tools that separate, identify, and quantify chemical compounds in complex mixtures. These instruments are essential in pharmaceutical drug development (every new drug must be analyzed for purity, potency, and stability), quality control in pharmaceutical manufacturing, food and beverage safety testing, environmental monitoring, and materials science research. Waters holds leading market positions in HPLC, where its ACQUITY UPLC systems set the industry standard for performance. The analytical instruments business has attractive characteristics: installed base generates recurring revenue from consumables (chromatography columns, reagents) and service contracts, regulatory requirements mandate the use of validated analytical methods, and instruments typically have 10-15 year replacement cycles creating predictable upgrade demand. Key stock drivers include pharmaceutical R&D spending, instrument replacement cycles, consumable and service revenue growth, competition with Agilent, Thermo Fisher, and Shimadzu, new product launches, Chinese market demand, and the pace of biopharmaceutical development driving analytical instrument needs.